BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $1.6 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.